Literature DB >> 20937616

Salvia divinorum use and phenomenology: results from an online survey.

H R Sumnall1, F Measham, S D Brandt, J C Cole.   

Abstract

Salvia divinorum is a hallucinogenic plant with ethnopharmacological and recreational uses. It differs from classic serotonergic hallucinogens such as LSD and psilocin in both phenomenology and potent agonist activity of the active component salvinorin A at κ-opioid receptors. Awareness of S. divinorum has grown recently, with both an increase in its public representation and concern over its potential harmful effects. This discussion is particularly relevant as S. divinorum is legal to use in many countries and regions and easily available through online retailers. Drawing upon previous investigations of S. divinorum and other hallucinogens, this study surveyed 154 recent users and questioned them on their use behaviours, consequences of use and other attitudinal measures. Although reporting an extensive substance use history, and considering the limitations of online surveys, there was little evidence of dysfunctional S. divinorum use, and few reports of troubling adverse consequences of use. Furthermore, there was no evidence that users exhibited increased schizotypy. Respondents reported that S. divinorum produced mixed hallucinogenic and dissociative effects, which lends support to assertions that it phenomenologically differs from other hallucinogens with primary serotonergic activity. The functions of use changed with greater experiences with the drug, and although many respondents reported use of S. divinorum as an alternative to illegal drugs it, was apparent that legal proscription would be unlikely to dissuade them from use. These results are discussed with reference to psychopharmacologically informed public health responses to substance use.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937616     DOI: 10.1177/0269881110385596

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  11 in total

1.  Use of Salvia divinorum in a nationally representative sample.

Authors:  Brian E Perron; Brian K Ahmedani; Michael G Vaughn; Joseph E Glass; Arnelyn Abdon; Li-Tzy Wu
Journal:  Am J Drug Alcohol Abuse       Date:  2011-08-11       Impact factor: 3.829

2.  Dose-related behavioral, subjective, endocrine, and psychophysiological effects of the κ opioid agonist Salvinorin A in humans.

Authors:  Mohini Ranganathan; Ashley Schnakenberg; Patrick D Skosnik; Bruce M Cohen; Brian Pittman; R Andrew Sewell; Deepak Cyril D'Souza
Journal:  Biol Psychiatry       Date:  2012-07-18       Impact factor: 13.382

Review 3.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 4.  Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.

Authors:  Christopher W Cunningham; Richard B Rothman; Thomas E Prisinzano
Journal:  Pharmacol Rev       Date:  2011-03-28       Impact factor: 25.468

5.  Reliability and validity of young adults' anonymous online reports of marijuana use and thoughts about use.

Authors:  Danielle E Ramo; Howard Liu; Judith J Prochaska
Journal:  Psychol Addict Behav       Date:  2011-11-14

6.  Abuse and Effects of Salvia divinorum in a Sample of Patients Hospitalized for Substance Dependence.

Authors:  Antoine Karam; Aida Said; Chafika Assaad; Souheil Hallit; Georges Haddad; Dory Hachem; Francois Kazour
Journal:  Community Ment Health J       Date:  2018-10-29

7.  Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects.

Authors:  Katherine A MacLean; Matthew W Johnson; Chad J Reissig; Thomas E Prisinzano; Roland R Griffiths
Journal:  Psychopharmacology (Berl)       Date:  2012-11-08       Impact factor: 4.530

8.  Recent national trends in Salvia divinorum use and substance-use disorders among recent and former Salvia divinorum users compared with nonusers.

Authors:  Li-Tzy Wu; George E Woody; Chongming Yang; Jih-Heng Li; Dan G Blazer
Journal:  Subst Abuse Rehabil       Date:  2011-04

9.  The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports.

Authors:  Camila Sanz; Federico Zamberlan; Earth Erowid; Fire Erowid; Enzo Tagliazucchi
Journal:  Front Neurosci       Date:  2018-01-22       Impact factor: 4.677

10.  Prevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey.

Authors:  Danielle E Ramo; Judith J Prochaska
Journal:  Addict Sci Clin Pract       Date:  2012-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.